Advisor Group Inc. grew its holdings in CVS Health Corp (NYSE:CVS) by 4.3% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 133,008 shares of the pharmacy operator’s stock after purchasing an additional 5,507 shares during the period. Advisor Group Inc.’s holdings in CVS Health were worth $10,491,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Horan Capital Advisors LLC. lifted its holdings in shares of CVS Health by 3.2% in the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock valued at $2,584,000 after purchasing an additional 1,000 shares in the last quarter. Community Bank N.A. raised its holdings in shares of CVS Health by 7.3% during the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after acquiring an additional 1,362 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of CVS Health by 3.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 176,294 shares of the pharmacy operator’s stock worth $13,840,000 after acquiring an additional 5,478 shares in the last quarter. Midwest Investment Management LLC raised its holdings in shares of CVS Health by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after acquiring an additional 1,245 shares in the last quarter. Finally, Fiduciary Trust Co. raised its holdings in shares of CVS Health by 1.2% during the first quarter. Fiduciary Trust Co. now owns 366,007 shares of the pharmacy operator’s stock worth $28,732,000 after acquiring an additional 4,265 shares in the last quarter. Institutional investors own 82.24% of the company’s stock.

In related news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares of the company’s stock, valued at $3,504,758.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Larry J. Merlo sold 241,150 shares of CVS Health stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $83.07, for a total value of $20,032,330.50. Following the sale, the insider now directly owns 299,255 shares in the company, valued at $24,859,112.85. The disclosure for this sale can be found here. Over the last three months, insiders have sold 714,125 shares of company stock worth $58,119,381. 0.61% of the stock is owned by company insiders.

Several brokerages recently issued reports on CVS. Jefferies Group set a $76.00 price objective on CVS Health and gave the stock a “hold” rating in a report on Monday. Needham & Company LLC increased their price objective on CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a report on Monday. Loop Capital set a $73.00 price objective on CVS Health and gave the stock a “hold” rating in a report on Monday. Robert W. Baird set a $77.00 price objective on CVS Health and gave the stock a “hold” rating in a report on Monday. Finally, Citigroup cut their price objective on CVS Health from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Thursday, August 17th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fifteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $86.35.

Shares of CVS Health Corp (NYSE CVS) traded down $0.68 during trading hours on Wednesday, hitting $71.01. The stock had a trading volume of 15,423,900 shares, compared to its average volume of 6,880,704. The firm has a market capitalization of $72,621.40, a P/E ratio of 12.56, a P/E/G ratio of 1.23 and a beta of 0.89. CVS Health Corp has a 12 month low of $66.45 and a 12 month high of $84.72. The company has a current ratio of 1.05, a quick ratio of 0.55 and a debt-to-equity ratio of 0.67.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion for the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the business posted $1.64 earnings per share. research analysts predict that CVS Health Corp will post 5.9 EPS for the current fiscal year.

WARNING: This news story was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/06/cvs-health-corp-cvs-shares-bought-by-advisor-group-inc.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corp and related stocks with our FREE daily email newsletter.